The expansion of a newly acquired facility in Wisconsin is Lilly’s largest U.S. manufacturing investment outside of Indiana ...
A study published in Nature estimates the economic burden associated with obesity on major US industries to be in excess of $347bn in 2023.
Conversely, Eduardo Grunvald, MD, medical director of the weight management program at UC San Diego Health, sees less of an ...
You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...
GLP-1 weight loss drugs such as Ozempic are on the rise. While their use is initially most prominent in the US, many predict ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Novo Nordisk, the manufacturer of Ozempic and Wegovy, has petitioned the Food and Drug Administration (FDA) to add ...
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 525.52% and ...
Amgen (NASDAQ: AMGN) recently released clinical results for its developmental weight loss drug MariTide. Shares fell by as ...
Rep. Brad Wenstrup, R-Ohio, said his bill on the topic creates a more holistic approach than simple government coverage by ...
Eli Lilly and Company announced a significant expansion at its Pleasant Prairie facility Thursday. The pharmaceutical giant plans a $3 billion investment, which is expected to create 750 new jobs at ...
This allows the body time to adjust and stabilize. Maternal health management: Weight loss drugs can have different ...